angiotensin ii has been researched along with gefitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, S; Fujigaki, Y; Hishida, A; Suzuki, H; Yamamoto, T | 1 |
| Aoki, H; Fukumoto, Y; Furusho, A; Hashimoto, Y; Hayashi-Hori, M; Hirakata, S; Ito, S; Majima, R; Matsukuma, M; Nishida, N; Ohno-Urabe, S | 1 |
2 other study(ies) available for angiotensin ii and gefitinib
| Article | Year |
|---|---|
Comparison of ROCK and EGFR activation pathways in the progression of glomerular injuries in AngII-infused rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Disease Progression; ErbB Receptors; Gefitinib; Kidney Diseases; Kidney Glomerulus; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction | 2011 |
Therapeutic Effect of Rapamycin on Aortic Dissection in Mice.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aortic Dissection; Cell Cycle Checkpoints; Cell Line; Disease Models, Animal; Gefitinib; Gene Expression Regulation; Gene Ontology; Gene Regulatory Networks; Male; Mice; Muscle, Smooth, Vascular; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; STAT3 Transcription Factor; TOR Serine-Threonine Kinases | 2020 |